Health and Healthcare
Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual meeting, and some traders and investors may be using this as a preview for what lies ahead at the American Society of Clinical Oncology (ASCO) annual meeting in a month. The following companies which are presenting data:
- Allos Therapeutics, Inc. (NASDAQ: ALTH)
- Amgen (NASDAQ: AMGN)
- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA)
- Array BioPharma, Inc. (NASDAQ: ARRY)
- AstraZeneca’s (NYSE: AZN) Medimmune unit
- Biogen Idec Inc. (NASDAQ: BIIB)
- Celgene Corporation (NASDAQ: CELG)
- Curis, Inc. (NASDAQ: CRIS)
- Immunomedics, Inc. (Nasdaq: IMMU)
- ImmunoGen, Inc. (Nasdaq: IMGN)
- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
- Medarex, Inc. (Nasdaq: MEDX)
- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA)
- Oncolytics Biotech, Inc. (NASDAQ: ONCY)
- Pfizer (NYSE: PFE)
- Pharmacyclics, Inc. (NASDAQ: PCYC)
- SuperGen Inc. (NASDAQ:SUPG)
- Telik, Inc. (Nasdaq: TELK)
- Threshold Pharmaceuticals, Inc. (Nasdaq: THLD)
You can see a full summary of the data being presented at BioHealthInvestor.com site. There will be others presenting data this weekend, and these were from the press releases of the meeting ahead of time.
JON C. OGG
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.